The latest report by IMARC Group, titled “Malaria Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on the Malaria Diagnostics Market Share. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global malaria diagnostics market size reached US$ 778.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,136.2 Million by 2028, exhibiting a growth rate (CAGR) of 6.3% during 2023-2028. Malaria is a severe disease caused by Plasmodium parasites that are transmitted through the bite of infected female Anopheles mosquito. Malaria diagnostics include various clinical tests conducted to ascertain the presence of the infection in an individual. They involve the microscopic examination of blood samples with antigen-based rapid diagnostic tests (RDT). These tests majorly use indirect immunofluorescence (IFA) or enzyme-linked immunosorbent assay (ELISA) detection techniques. Malaria diagnostics are widely performed in laboratories, hospitals, clinics, and research institutions.
Request for a free sample copy of this report: https://www.imarcgroup.com/malaria-diagnostics-market/requestsample
The increasing prevalence of malaria in emerging economies represents the key factor driving the global malaria diagnostics market growth. Additionally, rising awareness amongst consumers regarding the availability of point-of-care (POC) diagnostic devices and personalized treatment plans for malaria are propelling the market growth. In line with this, rising healthcare expenditure and the implementation of favorable policies for promoting public health are further catalyzing the market growth. Moreover, rapid technological advancements, such as the Quantitative Buffy Coat (QBC) and peripheral blood smear methods for novel malaria diagnostics, are creating a positive outlook for the market.
Competitive Landscape with Key Players:
- Abbott Laboratories
- Access Bio
- Beckman Coulter Inc. (Danaher Corporation)
- BioMérieux SA (Compagnie Merieux Alliance)
- Bio-Rad Laboratories Inc.
- Nikon Corporation
- Novartis AG
- Olympus Corporation
- Premier Medical Corporation Pvt. Ltd.
- Siemens Healthcare GmbH (Siemens AG)
- Sysmex Corporation
- Thermo Fisher Scientific Inc
Key Market Segmentation:
- Rapid Diagnostic Tests (RDTs)
- Molecular Diagnostic Tests
- Conventional PCR
- Real-Time PCR (qPCR)
- Diagnostic Centers
- North America
- Asia Pacific
- The Middle East and Africa
- Latin America
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St. Brooklyn, NY 11249, USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800